Tang Huaqi, He Shuaibing, Zhang Xinyue, Luo Shilin, Zhang Baixia, Duan Xiaojie, Zhang Zhiqian, Wang Wenqi, Wang Yun, Sun Yikun
School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China.
Evid Based Complement Alternat Med. 2016;2016:3246946. doi: 10.1155/2016/3246946. Epub 2016 Mar 24.
As the most familiar type of arthritis and a chronic illness of the joints, Osteoarthritis (OA) affects a great number of people on the global scale. XuanHuSuo powder (XHSP), a conventional herbal formula from China, has been extensively applied in OA treatment. Nonetheless, its pharmacological mechanism has not been completely expounded. In this research, a network pharmacology approach has been chosen to study the pharmacological mechanism of XHSP on OA, and the pharmacology networks were established based on the relationship between four herbs found in XHSP, compound targets, and OA targets. The pathway enrichment analysis revealed that the significant bioprocess networks of XHSP on OA were regulation of inflammation, interleukin-1β (IL-1β) production and nitric oxide (NO) biosynthetic process, response to cytokine or estrogen stimuli, and antiapoptosis. These effects have not been reported previously. The comprehensive network pharmacology approach developed by our research has revealed, for the first time, a connection between four herbs found in XHSP, corresponding compound targets, and OA pathway systems that are conducive to expanding the clinical application of XHSP. The proposed network pharmacology approach could be a promising complementary method by which researchers might better evaluate multitarget or multicomponent drugs on a systematic level.
骨关节炎(OA)作为最常见的关节炎类型和一种关节慢性病,在全球范围内影响着大量人群。玄胡索散(XHSP)是一种来自中国的传统中药配方,已广泛应用于OA治疗。然而,其药理机制尚未完全阐明。在本研究中,我们选择了网络药理学方法来研究XHSP对OA的药理机制,并基于XHSP中四种草药、化合物靶点和OA靶点之间的关系建立了药理学网络。通路富集分析表明,XHSP对OA的重要生物过程网络包括炎症调节、白细胞介素-1β(IL-1β)产生和一氧化氮(NO)生物合成过程、对细胞因子或雌激素刺激的反应以及抗凋亡。这些作用此前尚未见报道。我们的研究所开发的综合网络药理学方法首次揭示了XHSP中四种草药、相应的化合物靶点和OA通路系统之间的联系,这有助于扩大XHSP的临床应用。所提出的网络药理学方法可能是一种有前景的补充方法,通过该方法研究人员可以在系统水平上更好地评估多靶点或多组分药物。